A
Alfredo Carlo Altamura
Researcher at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Publications - 201
Citations - 3896
Alfredo Carlo Altamura is an academic researcher from Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. The author has contributed to research in topics: Bipolar disorder & Schizophrenia. The author has an hindex of 31, co-authored 201 publications receiving 3403 citations. Previous affiliations of Alfredo Carlo Altamura include University of Milan & University of Cagliari.
Papers
More filters
Journal ArticleDOI
Clinical pharmacology of atypical antipsychotics: an update.
Massimo Carlo Mauri,Silvia Paletta,M. Maffini,Alessandro Colasanti,Filippo Dragogna,C. Di Pace,Alfredo Carlo Altamura +6 more
TL;DR: Four new second-generation antipsychotics are available: iloperidone, asenapine, lurasidone and in the next future cariprazine, and these new agents are advisable for the lower propensity to give weight gain and metabolic abnormalities in comparison with older second- Generation antipsychotic drugs such as olanzapine or clozapine.
Journal ArticleDOI
Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study.
Alfredo Carlo Altamura,R. Bassetti,Stefano Bignotti,Rosaria Pioli,Emanuela Mundo,Emanuela Mundo +5 more
TL;DR: Investigation of the possible association between clinical or pharmacological variables and suicidal behavior in a sample of chronic schizophrenia or schizoaffective disorder patients found thatempters had a significantly higher rate of nicotine abuse or dependence than patients without suicidal attempts lifetime.
Journal ArticleDOI
Interactions between transcranial direct current stimulation (tDCS) and pharmacological interventions in the Major Depressive Episode: findings from a naturalistic study.
Andre R. Brunoni,Roberta Ferrucci,Marco Bortolomasi,Emma Scelzo,Paulo S. Boggio,Felipe Fregni,Bernardo Dell'Osso,M. Giacopuzzi,Alfredo Carlo Altamura +8 more
TL;DR: In this paper, the authors investigated the interactions between tDCS and drug therapy in unipolar and bipolar depressed patients who were refractory for at least one pharmacological treatment and found that tDCS over the DLPFC acutely improved depressive symptoms.
Journal ArticleDOI
Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study.
TL;DR: The logistic regression analysis results confirmed the DUP and the pre-treatment BPRS scores to be significant predictors of the outcome of first-episode schizophrenia, confirming that the timing in recognizing and treating the early symptoms of schizophrenia, even when subtle, is a core issue for the clinical management of the disorder.
Journal ArticleDOI
Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic study.
TL;DR: It is suggested that patients with different mood and anxiety disorders show significant differences in terms of age at onset, age at first treatment and, consequently, DUI, which potentially reflect different reasons influencing treatment delay.